Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantine Alifrangis

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
The Lancet. Oncology|January 10, 2012
Shark cartilage: has the popularisation of science failed?Constantine Alifrangis, Justin Stebbing
Future Oncology (London, England)|December 15, 2010
Genetics of gestational trophoblastic neoplasia: an update for the clinicianConstantine Alifrangis, Michael J Seckl
European Journal of Cancer (Oxford, England : 1990)|April 5, 2018
Letter to the Editor: Central nervous system relapse rate and dose intensification in poor risk metastatic germ cell tumours-A comment on: 'Patterns of relapse in poor prognosis germ cell tumours in the GETUG-13 trial: Implications for the assessment of brain metastases.' by Loriot and colleaguesConstantine Alifrangis, Peter Wilson, Jonathan Shamash
BMJ Case Reports|November 16, 2019
The management of patients with learning difficulties and testicular cancer: overcoming barriers to improve careCharlotte Emily Mott, Kenrick Ng, Constantine Alifrangis
International Journal of STD & AIDS|October 26, 2006
Primary pneumococcal peritonitis as a presenting feature of HIV infectionConstantine Alifrangis, Phillip Thompson, Guy Thwaites, et al.
Expert Review of Anticancer Therapy|March 21, 2018
Dose intense chemotherapy in the management of poor prognosis and relapsed testicular cancer: experiences and controversiesKenrick Ng, Sarah Duncan, Jonathan Shamash, et al.
BJU International|September 22, 2011
New drugs for prostate cancerConstantine Alifrangis, Ciara O'Hanlon-Brown, Mark Tuthill, et al.
Scottish Medical Journal|May 5, 2022
Management of stage II seminoma: a contemporary UK perspectiveConstantine Alifrangis, David L Nicol, Jonathan Shamash, et al.
Current Opinion in Urology|June 24, 2022
Decoding germ cell tumours for cliniciansAiman Haider, Clare Verrill, Constantine Alifrangis, et al.
Lancet (London, England)|September 15, 2009
Poor reception?Constantine Alifrangis, Jonny P Harcourt, Ondrej Gojis, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
The Lancet. Oncology|January 10, 2012
Shark cartilage: has the popularisation of science failed?Constantine Alifrangis, Justin Stebbing
Future Oncology (London, England)|December 15, 2010
Genetics of gestational trophoblastic neoplasia: an update for the clinicianConstantine Alifrangis, Michael J Seckl
European Journal of Cancer (Oxford, England : 1990)|April 5, 2018
Letter to the Editor: Central nervous system relapse rate and dose intensification in poor risk metastatic germ cell tumours-A comment on: 'Patterns of relapse in poor prognosis germ cell tumours in the GETUG-13 trial: Implications for the assessment of brain metastases.' by Loriot and colleaguesConstantine Alifrangis, Peter Wilson, Jonathan Shamash
BMJ Case Reports|November 16, 2019
The management of patients with learning difficulties and testicular cancer: overcoming barriers to improve careCharlotte Emily Mott, Kenrick Ng, Constantine Alifrangis
International Journal of STD & AIDS|October 26, 2006
Primary pneumococcal peritonitis as a presenting feature of HIV infectionConstantine Alifrangis, Phillip Thompson, Guy Thwaites, et al.
Expert Review of Anticancer Therapy|March 21, 2018
Dose intense chemotherapy in the management of poor prognosis and relapsed testicular cancer: experiences and controversiesKenrick Ng, Sarah Duncan, Jonathan Shamash, et al.
BJU International|September 22, 2011
New drugs for prostate cancerConstantine Alifrangis, Ciara O'Hanlon-Brown, Mark Tuthill, et al.
Scottish Medical Journal|May 5, 2022
Management of stage II seminoma: a contemporary UK perspectiveConstantine Alifrangis, David L Nicol, Jonathan Shamash, et al.
Current Opinion in Urology|June 24, 2022
Decoding germ cell tumours for cliniciansAiman Haider, Clare Verrill, Constantine Alifrangis, et al.
Lancet (London, England)|September 15, 2009
Poor reception?Constantine Alifrangis, Jonny P Harcourt, Ondrej Gojis, et al.
Pageof 6